IFNG and thyroid gland carcinoma: Research in thyroid cancer has revealed that Th1 lymphocytes can stimulate production of interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), leading to release of CXCL10 and CXCL8.